Comparison ofL‐Carnitine Pharmacokinetics With and Without Baseline Correction Following Administration of Single 20–mglkg Intravenous Dose
- 1 May 1995
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 84 (5) , 634-639
- https://doi.org/10.1002/jps.2600840521
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pharmacokinetics and safety of l-carnitine infused i. v. in healthy subjectsEuropean Journal of Clinical Pharmacology, 1988
- Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjectsEuropean Journal of Clinical Pharmacology, 1988
- l-CarnitineDrugs, 1987
- Successful Carnitine Treatment in Two Siblings Having Lipid Storage Myopathy with Hypertrophic CardiomyopathyNeuropediatrics, 1985
- Fat metabolism following an intravenous bolus dose of a fat emulsion and carnitineClinical Physiology and Functional Imaging, 1984
- Systemic carnitine deficiencyNeurology, 1984
- The role of L-carnitine in the pathogenesis of cardiomegaly in patients with chronic hemodialysis.Japanese Circulation Journal, 1983
- Carnitine deficiency presenting as familial cardiomyopathy: A treatable defect in carnitine transportThe Journal of Pediatrics, 1982
- Primary systemic carnitine dehciency. II. Renal handling of carnitineNeurology, 1981